Supplemental Table 1. Baseline characteristics of study patients with acute ischemic stroke.
| Characteristics | Enrolled (n = 1,090) | Excluded (n = 203) | P Value |
|---|---|---|---|
| Age, y | 60.09 ± 12.78 | 60.42 ± 11.80 | 0.803 |
| Male | 714 (62.9%) | 61 (54.5%) | 0.074 |
| Smoking | 417 (38.3%) | 65 (32.2%) | 0.217 |
| Statin use history | 66 (6.1%) | 18 (8.9%) | 0.668 |
| NIHSS score at admission | 3 (2–6) | 3 (1–6) | 0.868 |
| Hypertension | 604 (53.3%) | 71 (63.4%) | 0.030 |
| CHD | 119 (10.5%) | 22 (12.7%) | 0.059 |
| Atrial fibrillation | 57 (5%) | 14 (8.5%) | 0.148 |
| Diabetes mellitus | 198 (17.5%) | 299 (18.3%) | 0.610 |
| Stroke | 209 (18.4%) | 30 (18.9%) | 0.702 |
| Dyslipidemia | 78 (6.9%) | 11 (6.5) | 0.633 |
| WBC, 109/L | 7.51 (6.31–8.51) | 7.61 (6.13–9.67) | 0.608 |
| Neutrophil, 109/L | 5.10 (3.91–6.11) | 5.15 (3.88–7.21) | 0.471 |
| Lymphocyte, 109/L | 1.71 (1.31–2.11) | 1.65 (0.95–2.15) | 0.638 |
| MONO, 109/L | 0.56 (0.48–0.63) | 0.61 (0.45–0.79) | 0.333 |
| CHO, mmol/L | 4.07 (3.46–4.77) | 4.16 (3.11–4.70) | 0.571 |
| TG, mmol/L | 1.37 (1.01–2.01) | 1.35 (0.91–1.89) | 0.309 |
| LDL-C, mmol/L | 2.49 (1.93–3.06) | 2.63 (1.75–3.18) | 0.742 |
| HDL-C, mmol/L | 1.06 (0.91–1.24) | 1.06 (0.89–1.33) | 0.923 |
| MHR | 0.48 (0.35–0.61) | 0.46 (0.34–0.64) | 0.934 |
NIHSS, National Institutes of Health Stroke Scale; CHD, coronary heart disease; WBC, white blood cell, MONO, monocyte; CHO, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein; HDL-C, high-density lipoprotein and MHR, monocyte to high-density lipoprotein ratio.